FORSYTH DOUGLAS · Inhibrx Biosciences, Inc. · 55d agono track record yet
Long 2,500 shares of INBX
Bought 2,500 @ $114.65 avg · $286,617 · 2026-09-08
Form 4: FORSYTH DOUGLAS bought INBX
FORSYTH DOUGLAS (Director at Inhibrx Biosciences, Inc.) reported an open-market purchase of 2,500 shares of INBX at an average $114.65, roughly $286,617, in a Form 4 filed 2026-09-08.
At post $114.34Now $72.16-36.9% since postedas of Nov 2, 4:15 PM ET
1d-1.3%
3d-4.4%
1w-7.6%
1m-18.9%
3m—
6m—
1y—